Professor Andrew Lo on the Cancer Mega-Fund – Will Financial Engineering Cure Cancer?
This Financial Sense Newshour program is available only as a premium, paid "FS Insider" release.
For advance notice of release of premium, paid "FS Insider" content or to purchase a monthly or annual subscription to "FS Insider" content, go to www.financialsense.com/subscribe.
Jim welcomes back Dr. Andrew Lo, Professor of Finance at the MIT Sloan School of Management and the director of MIT's Laboratory for Financial Engineering. They discuss Professor Lo’s proposal to use financial engineering to spread risks among investors and provide financial incentives to develop successful cancer treatments. Professor Lo notes that pharmaceutical companies feel challenged because there isn’t enough funding at the early stages of clinical research, and the pipeline is becoming thinner and thinner because there’s less and less venture capital money going into the industry. He explains how the Cancer Mega-Fund works, and how investors can make good money in finding a cure for cancer. In 2012 Time Magazine named Andrew Lo to its list of the 100 most influential people in the world.
About James J Puplava CFP
|11/25/2017||Investment Strategy Conference Part 3 With Jim Puplava||bcast|
|11/24/2017||Investment Strategy Conference Part 1 With Jim Puplava||bcast|
|11/23/2017||Don Coxe on Real Assets and What the Market Does Not Know||bcast|
|11/20/2017||Disturbing Trends in 401Ks and IRAs||bcast|
|11/18/2017||The Future of Oil/Investment Opportunities||bcast|
|11/18/2017||Dave Nicoski on Short-Term Consolidation in the Stock Market; John Ing on Why He Believes Gold Has Peaked||bcast|
|11/16/2017||Book Interview: Scott Galloway on The Four: The Hidden DNA of Amazon, Apple, Facebook, and Google||bcast|
|11/14/2017||Yolanda York on Applying For Social Security and Medicare||bcast|
|11/13/2017||Tax Reform – Urgent – Call Your Advisor!||bcast|